{"id":"W4307775795","doi":"10.1684/ejd.2022.4280","title":"Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib with in five Phase III clinical trials","year":2022,"lang":"en","type":"article","venue":"European Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"EMD Serono; LEO Pharma; Kyowa Hakko Kirin; Sanofi Genzyme; Incyte; Kiniksa Pharmaceuticals; Kyowa Kirin Pharmaceutical Development; Dermira; Regeneron Pharmaceuticals; Sanofi; Oregon Health and Science University; Les Laboratories Pierre Fabre; Celgene; Amgen; Pfizer; Galderma; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Head and neck; Dermatology; Clinical trial; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004310071,0.000932871,0.002289956,0.000520584,0.0004443793,0.001369657,0.001026568,0.0009567752,0.002877333],"category_scores_gemma":[0.002293291,0.0003272122,0.002726719,0.0006030986,0.000549459,0.0005509946,0.0003844625,0.001768731,0.0003385555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001185709,"about_ca_system_score_gemma":0.001696139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001582767,"about_ca_topic_score_gemma":0.005546973,"domain_scores_codex":[0.9990574,0.0004674333,0.0001146405,0.00009157186,0.0001014557,0.0001674389],"domain_scores_gemma":[0.9985462,0.0004115585,0.0004384089,0.00009324228,0.0002105548,0.0003000449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7663917,0.01382734,0.00885707,0.01557457,0.01843973,0.0001946518,0.0003659159,0.002470023,0.01553266,0.0007016917,0.009111394,0.1485332],"study_design_scores_gemma":[0.8036879,0.1518346,0.01914751,0.001031247,0.009978732,0.0002567152,0.000135375,0.001085926,0.002688307,0.0003184937,0.009784056,0.00005124633],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9162504,0.058403,0.00169319,0.001808148,0.0007591009,0.008719252,0.004066086,0.000269201,0.008031597],"genre_scores_gemma":[0.9649388,0.01997313,0.002337456,0.002061173,0.0002295648,0.004808147,0.003524229,0.00002043914,0.002107054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004310071,"threshold_uncertainty_score":0.02279413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02310291459643472,"score_gpt":0.3195896760651961,"score_spread":0.2964867614687614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}